Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Caitlin E. Cox

August 13, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

ACC Updates Pathway for Hospitalized HF Patients

Todd Neale

August 12, 2024

News Daily News

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

L.A. McKeown

February 23, 2024

News Daily News

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

Michael O'Riordan

September 27, 2023

News Daily News

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Michael O'Riordan

September 18, 2023

News Daily News

CPR Manikins on Social Media Have a Diversity Problem

Shelley Wood

November 22, 2022

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Caitlin E. Cox

January 10, 2022

News Daily News

Diabetes Duration and Meds Don’t Impact Ticagrelor Effects in THEMIS

Todd Neale

May 14, 2021

News Daily News

Site Investigators Missed Clinical Events in GLOBAL LEADERS

Michael O'Riordan

February 12, 2021

News Daily News

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

Shelley Wood

May 06, 2020

News Daily News

Tricuspid Interventions OK With Pacemakers, ICDs: TriValve Registry

Todd Neale

January 17, 2020

Advertisement

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

ACC Updates Pathway for Hospitalized HF Patients

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

CPR Manikins on Social Media Have a Diversity Problem

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Diabetes Duration and Meds Don’t Impact Ticagrelor Effects in THEMIS

Site Investigators Missed Clinical Events in GLOBAL LEADERS

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

Tricuspid Interventions OK With Pacemakers, ICDs: TriValve Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content